Hillhouse Capital Management - CONSTELLATION PHARMCETICLS I ownership

Quarter-by-quarter ownership
Hillhouse Capital Management ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2019$3,904,000
-9.4%
317,9210.0%0.12%
-30.6%
Q1 2019$4,308,000
+237.9%
317,9210.0%0.18%
+89.5%
Q4 2018$1,275,000
-40.4%
317,9210.0%0.10%
+66.7%
Q3 2018$2,140,000317,9210.06%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q3 2023
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$53,209,00043.12%
Ponoi Management, LLC 1,880,623$63,565,00035.32%
Column Group LLC 2,626,631$88,780,00012.57%
Euclidean Capital LLC 554,325$18,736,0006.08%
Chicago Capital Management, LLC 295,878$10,001,0005.60%
COMMODORE CAPITAL LP 440,869$14,901,0005.19%
Samson Rock Capital LLP 467,072$15,787,0003.11%
S. MUOIO & CO. LLC 105,000$3,549,0003.01%
Omni Partners US LLC 1,815,117$61,351,0002.70%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 621,541$21,008,0002.68%
View complete list of CONSTELLATION PHARMCETICLS I shareholders